Title
Category
Credits
Event date
Cost
  • PAINWeek
$49.00
Cannabinoid prescription medications are available across the globe and right here in America. More are in the pipeline. Where do and will these products be placed and how will they work?
  • CMHC
  • 1.75 ACPE Pharmacy
  • 1.75 AMA PRA Category 1 Credit
  • 1.75 ANCC
  • 1.75 Participation
$0.00
Idiopathic hypersomnia (IH) is a chronic neurological disorder that has significant impacts on daily functioning, with symptoms that include, but often go beyond excessive daytime sleepiness (EDS). Overall awareness about IH remains low, which contributes to the suboptimal recognition of this condition, which is often exacerbated by insufficient diagnostic criteria leading to delayed diagnosis and treatment.
  • CMHC
  • 19.25 ACPE Pharmacy
  • 19.25 AMA PRA Category 1 Credit
  • 19.25 ANCC
  • 19.25 CDE
  • 19.25 Participation
$0.00
The recordings from the 18th Annual meeting are now available. 
  • CMHC
  • 0.75 ACPE Pharmacy
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC
  • 0.75 Participation
$0.00
This clinical brief was developed from a presentation at the 2023 Women's Health and Wellness Masterclass held August 2023 in Dana Point, CA. The session, “Resistant Hypertension in Women: Dispelling Common Myths and Recent Clinical Advances,” was presented by Keith C. Ferdinand, MD, supported by an educational grant from Medtronic.
  • CMHC
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation
$0.00
This activity consists of a recorded presentation at the 18th annual CMHC Annual Congress held from October 18-21, 2023, in Boston, MA. The session, “Tackling the Disproportionate Burden of Resistant Hypertension in Black Adults: Perspectives & Advances,” was presented by Keith C. Ferdinand, MD, and Debbie Cohen, MD. Drs. Ferdinand and Cohen discussed:The strategies to overcome barriers to hypertension control and cardiovascular diseases.The definitions, current treatment, and emerging approaches for resistant hypertension.
  • CMHC
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 ANCC
  • 1.50 Participation
$0.00
Atherosclerotic cardiovascular disease (ASCVD) events are among the leading causes of death in women in the US and globally. Even with advances in LDL-C (low-density lipoprotein cholesterol) lowering therapy, LDL-C goal achievement in high-risk women is lower than that in men, with clinical inertia, statin intolerance, and non-adherence being major factors.
  • CMHC
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation
$0.00
Several cardiometabolic comorbidities are common in patients with narcolepsy.  Often these disorders are overlooked, but they have important implications in the management of this condition. Some medications used to treat symptoms of narcolepsy may have potential negative effects on cardiovascular health, including in patients that are sensitive to sodium, such as those with hypertension or other cardiovascular risk factors.
  • CMHC
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation
$0.00
Iron deficiency (ID) with or without anemia is a common comorbidity in patients with heart failure (HF), and it can have significant impacts on morbidity and mortality. Intravenous (i.v.) iron repletion in HF patients with ID can improve symptoms, quality of life, and outcomes, and this evidence has been reflected accordingly in HF guidelines, in addition to a recent FDA approval. During this activity, experts discuss the latest evidence and considerations about the screening, diagnosis, and treatment of ID in patients with HF.

Pages